Invenra Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
57
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Invenra General Information
Description
Developer of a drug research platform designed to help discover and optimize human multi-specific antibodies. The company's platform is used to discover and develop new biologic drugs for cancer, Alzheimer's disease, and diabetes, enabling healthcare institutes to optimize bispecific formatting, binding affinities, candidate pairings, and linkers in biologically relevant assays.
Contact Information
Website
www.invenra.comCorporate Office
- 5510 Element Way
- Suite 400
- Madison, WI 53719
- United States
Corporate Office
- 5510 Element Way
- Suite 400
- Madison, WI 53719
- United States
Invenra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 16-Oct-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 03-Oct-2017 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Sep-2015 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 01-Jan-2015 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 19-Feb-2013 | $3M | $4.2M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC | 18-Jan-2012 | $1.2M | $1.2M | Completed | Pre-Clinical Trials |
Invenra Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Invenra Comparisons
Industry
Financing
Details
Invenra Competitors (85)
One of Invenra’s 85 competitors is Vividion Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vividion Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Euclises | Venture Capital-Backed | Saint Louis, MO | ||||
| BioTheryx | Venture Capital-Backed | San Diego, CA | ||||
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA | ||||
| Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL |
Invenra Patents
Invenra Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026152157-A2 | Domain pair | Pending | 13-Jan-2025 | ||
| WO-2026152157-A3 | Domain pair | Pending | 13-Jan-2025 | ||
| WO-2026152160-A2 | Domain pair for antibody constructs | Pending | 13-Jan-2025 | ||
| EP-4824105-A1 | Multispecific binding agents that target ctla4 and/or cd25 and uses thereof | Pending | 14-Dec-2023 | ||
| WO-2025129132-A1 | Multispecific binding agents that target ctla4 and/or cd25 and uses thereof | Inactive | 14-Dec-2023 | C07K16/2818 |
Invenra Signals
Invenra Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clarevia Ventures | Venture Capital | Minority | ||
| Rose Ventures | Venture Capital | Minority | ||
| Wisconsin Investment Partners | Angel Group | Minority |
Invenra Investments (1)
Invenra’s most recent deal was a Joint Venture with WIN Therapeutics.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WIN Therapeutics | Joint Venture | Drug Discovery |
Invenra FAQs
-
When was Invenra founded?
Invenra was founded in 2011.
-
Where is Invenra headquartered?
Invenra is headquartered in Madison, WI.
-
What is the size of Invenra?
Invenra has 57 total employees.
-
What industry is Invenra in?
Invenra’s primary industry is Drug Discovery.
-
Is Invenra a private or public company?
Invenra is a Private company.
-
What is Invenra’s current revenue?
The current revenue for Invenra is .
-
How much funding has Invenra raised over time?
Invenra has raised $21.3M.
-
Who are Invenra’s investors?
Clarevia Ventures, Rose Ventures, and Wisconsin Investment Partners have invested in Invenra.
-
Who are Invenra’s competitors?
Vividion Therapeutics, Euclises, BioTheryx, Actym Therapeutics, and Cantex Pharmaceuticals are some of the 85 competitors of Invenra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process